Structure base drug discovery company
Amura Holdings Ltd., Minerva Building, Babraham Research Campus, Babraham, CB22 3AT, U.K.
Home
Company
Technologies
Programmes
Contact
Sitemap
Search
 
 
     
 

Welcome to Amura

Amura is a company dedicated to the invention of new technologies, innovative medicines and novel products for improving health.

Amura’s therapeutic focus is in the areas of osteoporosis, bone metastasis, autoimmunity (e.g. rheumatoid arthritis, osteoarthritis, psoriasis, etc.), chronic pain and malaria.

Amura's AMcore™ scaffold is the premier chemical solution to cysteine peptidase inhibitor design; providing Amura with significant competitive advantage in highly attractive therapeutic indications.

Amura's products encompass its pre-clinical therapeutic programmes and intellectual property; which will be developed by strategic alliances with globally-recognised licensing partners.

 

 
Email: amura@amura.co.uk
Phone: +44(0)1223 839797 Fax: +44(0)1223 839898 Copyright © 2008 Amura Holdings Ltd.
Powered by www.dotscoms.co.uk